FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1973059778> ?p ?o ?g. }

• W1973059778 endingPage "24" @default.
• W1973059778 startingPage "15" @default.
• W1973059778 abstract "Summary BAX326 is a recombinant factor IX (rFIX; nonacog gamma) manufactured without the addition of any materials of human or animal origin, and with two viral inactivation steps (solvent/detergent treatment and 15 nm nanofiltration). The aim of this prospective trial was to investigate the pharmacokinetics, haemostatic efficacy and safety of BAX326 in previously treated patients aged 12–65 years with severe or moderately severe haemophilia B. BAX326 was safe and well tolerated in all 73 treated subjects; adverse events considered related to treatment (2.7% incidence, all non‐serious) were transient and mild, and no hypersensitivity reactions, inhibitor formation or thrombotic events were observed. Pharmacokinetic (PK) equivalence ( n = 28) between BAX326 and a licensed rFIX was confirmed in terms of the ratio of geometric mean AUC 0–72 h per dose. Twice‐weekly prophylaxis [mean duration 6.2 (±0.7) months; 1.8 (±0.1) infusions per week, 49.5 (±4.8) IU kg −1 per infusion] was effective in preventing bleeding episodes, with a significantly lower (79%, P < 0.001) annualized bleed rate (4.2) compared to an on‐demand treatment in a historical control group (20.0); 24 of 56 subjects on prophylaxis (43%) did not bleed throughout the study observation period. Of 249 total acute bleeds, 211 (84.7%) were controlled with one to two infusions of BAX326. Haemostatic efficacy at resolution of bleed was rated excellent or good in 96.0% of all treated bleeding episodes. The results of this study indicate that BAX326 is safe and efficacious in treating bleeds and routine prophylaxis in patients aged 12 years and older with haemophilia B." @default.
• W1973059778 created "2016-06-24" @default.
• W1973059778 creator A5010852837 @default.
• W1973059778 creator A5016306582 @default.
• W1973059778 creator A5022050468 @default.
• W1973059778 creator A5033329526 @default.
• W1973059778 creator A5037393708 @default.
• W1973059778 creator A5042493802 @default.
• W1973059778 creator A5042893306 @default.
• W1973059778 creator A5054363370 @default.
• W1973059778 creator A5064943069 @default.
• W1973059778 creator A5070415689 @default.
• W1973059778 creator A5071600573 @default.
• W1973059778 creator A5083717158 @default.
• W1973059778 date "2013-07-09" @default.
• W1973059778 modified "2023-10-02" @default.
• W1973059778 title "Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: a prospective, controlled, multicentre phase I/III study in previously treated patients with severe (FIX level <1%) or moderately severe (FIX level ≤2%) haemophilia B" @default.
• W1973059778 cites W117340189 @default.
• W1973059778 cites W1426203004 @default.
• W1973059778 cites W1524661434 @default.
• W1973059778 cites W1604030477 @default.
• W1973059778 cites W1709733250 @default.
• W1973059778 cites W1948716229 @default.
• W1973059778 cites W1964747396 @default.
• W1973059778 cites W1969941406 @default.
• W1973059778 cites W1983334571 @default.
• W1973059778 cites W1989584805 @default.
• W1973059778 cites W1995263453 @default.
• W1973059778 cites W2011719954 @default.
• W1973059778 cites W2026502021 @default.
• W1973059778 cites W2030072508 @default.
• W1973059778 cites W2036449069 @default.
• W1973059778 cites W2051724757 @default.
• W1973059778 cites W2086524535 @default.
• W1973059778 cites W2091721067 @default.
• W1973059778 cites W2099568190 @default.
• W1973059778 cites W2101010021 @default.
• W1973059778 cites W2101694407 @default.
• W1973059778 cites W2103499505 @default.
• W1973059778 cites W2108177522 @default.
• W1973059778 cites W2109130849 @default.
• W1973059778 cites W2116074621 @default.
• W1973059778 cites W2126147481 @default.
• W1973059778 cites W2135468468 @default.
• W1973059778 cites W2137326512 @default.
• W1973059778 cites W2149564822 @default.
• W1973059778 cites W35175100 @default.
• W1973059778 doi "https://doi.org/10.1111/hae.12228" @default.
• W1973059778 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23834666" @default.
• W1973059778 hasPublicationYear "2013" @default.
• W1973059778 type Work @default.
• W1973059778 sameAs 1973059778 @default.
• W1973059778 citedByCount "42" @default.
• W1973059778 countsByYear W19730597782013 @default.
• W1973059778 countsByYear W19730597782014 @default.
• W1973059778 countsByYear W19730597782015 @default.
• W1973059778 countsByYear W19730597782016 @default.
• W1973059778 countsByYear W19730597782017 @default.
• W1973059778 countsByYear W19730597782018 @default.
• W1973059778 countsByYear W19730597782019 @default.
• W1973059778 countsByYear W19730597782020 @default.
• W1973059778 countsByYear W19730597782021 @default.
• W1973059778 countsByYear W19730597782022 @default.
• W1973059778 countsByYear W19730597782023 @default.
• W1973059778 crossrefType "journal-article" @default.
• W1973059778 hasAuthorship W1973059778A5010852837 @default.
• W1973059778 hasAuthorship W1973059778A5016306582 @default.
• W1973059778 hasAuthorship W1973059778A5022050468 @default.
• W1973059778 hasAuthorship W1973059778A5033329526 @default.
• W1973059778 hasAuthorship W1973059778A5037393708 @default.
• W1973059778 hasAuthorship W1973059778A5042493802 @default.
• W1973059778 hasAuthorship W1973059778A5042893306 @default.
• W1973059778 hasAuthorship W1973059778A5054363370 @default.
• W1973059778 hasAuthorship W1973059778A5064943069 @default.
• W1973059778 hasAuthorship W1973059778A5070415689 @default.
• W1973059778 hasAuthorship W1973059778A5071600573 @default.
• W1973059778 hasAuthorship W1973059778A5083717158 @default.
• W1973059778 hasConcept C112705442 @default.
• W1973059778 hasConcept C120665830 @default.
• W1973059778 hasConcept C121332964 @default.
• W1973059778 hasConcept C126322002 @default.
• W1973059778 hasConcept C141071460 @default.
• W1973059778 hasConcept C188816634 @default.
• W1973059778 hasConcept C197934379 @default.
• W1973059778 hasConcept C2776259030 @default.
• W1973059778 hasConcept C2777081929 @default.
• W1973059778 hasConcept C2777232031 @default.
• W1973059778 hasConcept C2777288759 @default.
• W1973059778 hasConcept C2778385053 @default.
• W1973059778 hasConcept C2781221834 @default.
• W1973059778 hasConcept C61511704 @default.
• W1973059778 hasConcept C71924100 @default.
• W1973059778 hasConcept C90924648 @default.
• W1973059778 hasConceptScore W1973059778C112705442 @default.
• W1973059778 hasConceptScore W1973059778C120665830 @default.
• W1973059778 hasConceptScore W1973059778C121332964 @default.
• W1973059778 hasConceptScore W1973059778C126322002 @default.
• W1973059778 hasConceptScore W1973059778C141071460 @default.

• next